Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	SETD1A MECOM SETD3 NSD3	2.11e-05	44	74	4	GO:0140938
GeneOntologyMolecularFunction	glucosidase activity	GBA3 GANAB GBA2	2.15e-05	15	74	3	GO:0015926
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	SETD1A SETD3 NSD3	5.32e-05	20	74	3	GO:0042800
GeneOntologyMolecularFunction	glucosylceramidase activity	GBA3 GBA2	8.09e-05	4	74	2	GO:0004348
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	SETD1A MECOM SETD3 NSD3	1.18e-04	68	74	4	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	SETD1A MECOM SETD3 NSD3	1.25e-04	69	74	4	GO:0016278
GeneOntologyMolecularFunction	galactosylceramidase activity	GBA3 GBA2	1.35e-04	5	74	2	GO:0004336
GeneOntologyMolecularFunction	histone methyltransferase activity	SETD1A MECOM SETD3 NSD3	1.40e-04	71	74	4	GO:0042054
GeneOntologyMolecularFunction	hydrolase activity, acting on glycosyl bonds	GBA3 GANAB OTOGL SMPD1 GBA2	1.96e-04	144	74	5	GO:0016798
GeneOntologyMolecularFunction	beta-glucosidase activity	GBA3 GBA2	2.01e-04	6	74	2	GO:0008422
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing O-glycosyl compounds	GBA3 GANAB OTOGL GBA2	5.82e-04	103	74	4	GO:0004553
GeneOntologyMolecularFunction	protein methyltransferase activity	SETD1A MECOM SETD3 NSD3	5.82e-04	103	74	4	GO:0008276
GeneOntologyMolecularFunction	N-methyltransferase activity	SETD1A MECOM SETD3 NSD3	6.26e-04	105	74	4	GO:0008170
GeneOntologyMolecularFunction	extracellular matrix structural constituent	PXDN COL6A5 BMPER MUC5AC HAPLN1	6.68e-04	188	74	5	GO:0005201
GeneOntologyMolecularFunction	histone H3K36 methyltransferase activity	SETD3 NSD3	1.03e-03	13	74	2	GO:0046975
GeneOntologyMolecularFunction	histone modifying activity	USP36 SETD1A MECOM SETD3 NSD3	1.61e-03	229	74	5	GO:0140993
GeneOntologyCellularComponent	extracellular matrix	PXDN CLU OTOGL ADAMTS20 LINGO3 COL6A5 BMPER FCN3 MMP15 MUC5AC HAPLN1	1.85e-05	656	74	11	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	PXDN CLU OTOGL ADAMTS20 LINGO3 COL6A5 BMPER FCN3 MMP15 MUC5AC HAPLN1	1.91e-05	658	74	11	GO:0030312
Domain	VWC	PXDN BMPER MUC5AC	1.90e-04	28	75	3	PF00093
Domain	VWFC_1	PXDN BMPER MUC5AC	4.04e-04	36	75	3	PS01208
Domain	VWC	PXDN BMPER MUC5AC	4.74e-04	38	75	3	SM00214
Domain	VWFC_2	PXDN BMPER MUC5AC	4.74e-04	38	75	3	PS50184
Domain	SET	SETD1A SETD3 NSD3	5.94e-04	41	75	3	PF00856
Domain	VWF_dom	PXDN BMPER MUC5AC	6.38e-04	42	75	3	IPR001007
Domain	TIL	BMPER MUC5AC	1.02e-03	12	75	2	PF01826
Domain	C8	BMPER MUC5AC	1.02e-03	12	75	2	PF08742
Domain	SET_dom	SETD1A SETD3 NSD3	1.06e-03	50	75	3	IPR001214
Domain	SET	SETD1A SETD3 NSD3	1.06e-03	50	75	3	PS50280
Domain	Unchr_dom_Cys-rich	BMPER MUC5AC	1.21e-03	13	75	2	IPR014853
Domain	C8	BMPER MUC5AC	1.21e-03	13	75	2	SM00832
Domain	TIL_dom	BMPER MUC5AC	1.40e-03	14	75	2	IPR002919
Domain	Post-SET_dom	SETD1A NSD3	1.84e-03	16	75	2	IPR003616
Domain	VWD	BMPER MUC5AC	1.84e-03	16	75	2	SM00216
Domain	PostSET	SETD1A NSD3	1.84e-03	16	75	2	SM00508
Domain	VWF_type-D	BMPER MUC5AC	1.84e-03	16	75	2	IPR001846
Domain	VWFD	BMPER MUC5AC	1.84e-03	16	75	2	PS51233
Domain	POST_SET	SETD1A NSD3	1.84e-03	16	75	2	PS50868
Domain	VWD	BMPER MUC5AC	1.84e-03	16	75	2	PF00094
Domain	PWWP	HDGFL1 NSD3	2.88e-03	20	75	2	SM00293
Domain	PWWP	HDGFL1 NSD3	3.81e-03	23	75	2	PF00855
Domain	PWWP_dom	HDGFL1 NSD3	3.81e-03	23	75	2	IPR000313
Domain	PWWP	HDGFL1 NSD3	4.15e-03	24	75	2	PS50812
Pubmed	N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization.	GBA3 GANAB GBA2	2.00e-07	6	76	3	16547752
Pubmed	Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity.	GBA3 GANAB GBA2	2.00e-07	6	76	3	1704656
Pubmed	Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design.	GBA3 GANAB GBA2	2.00e-07	6	76	3	12719582
Pubmed	Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase.	GBA3 GANAB GBA2	2.00e-07	6	76	3	2959866
Pubmed	Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding.	GBA3 GANAB GBA2	3.49e-07	7	76	3	2076345
Pubmed	AIDS and glycosylation.	GBA3 GANAB GBA2	3.49e-07	7	76	3	2136376
Pubmed	Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.	CSNK1D CSNK1E	4.71e-06	2	76	2	19043076
Pubmed	CK1δ and CK1ε are components of human 40S subunit precursors required for cytoplasmic 40S maturation.	CSNK1D CSNK1E	4.71e-06	2	76	2	24424021
Pubmed	Regulation of casein kinase I epsilon and casein kinase I delta by an in vivo futile phosphorylation cycle.	CSNK1D CSNK1E	4.71e-06	2	76	2	9632646
Pubmed	Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.	CLU CR1	4.71e-06	2	76	2	23643458
Pubmed	Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.	CSNK1D CSNK1E	4.71e-06	2	76	2	25404202
Pubmed	An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disorders.	CSNK1D CSNK1E	4.71e-06	2	76	2	22981886
Pubmed	Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.	GBA3 GANAB GBA2	6.67e-06	17	76	3	2355006
Pubmed	Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin.	GBA3 GANAB GBA2	1.11e-05	20	76	3	12560567
Pubmed	An exploratory study on CLU, CR1 and PICALM and Parkinson disease.	CLU CR1	1.41e-05	3	76	2	21912625
Pubmed	Targeting of the circadian clock via CK1δ/ε to improve glucose homeostasis in obesity.	CSNK1D CSNK1E	1.41e-05	3	76	2	27439882
Pubmed	Genetic variations in the CLU and PICALM genes are associated with cognitive function in the oldest old.	CLU CR1	1.41e-05	3	76	2	20739100
Pubmed	Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study.	CLU CR1	1.41e-05	3	76	2	22952074
Pubmed	CKIepsilon/delta-dependent phosphorylation is a temperature-insensitive, period-determining process in the mammalian circadian clock.	CSNK1D CSNK1E	1.41e-05	3	76	2	19805222
Pubmed	Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450.	CSNK1D CSNK1E	1.41e-05	3	76	2	12270714
Pubmed	Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population.	CLU CR1	1.41e-05	3	76	2	22015308
Pubmed	The Impact of Complement Genes on the Risk of Late-Onset Alzheimer's Disease.	CLU CR1	1.41e-05	3	76	2	33804666
Pubmed	Casein kinase 1 proteomics reveal prohibitin 2 function in molecular clock.	CSNK1D CSNK1E	1.41e-05	3	76	2	22384121
Pubmed	Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer's disease patients.	CLU CR1	1.41e-05	3	76	2	32991610
Pubmed	Gene expression levels of Casein kinase 1 (CK1) isoforms are correlated to adiponectin levels in adipose tissue of morbid obese patients and site-specific phosphorylation mediated by CK1 influences multimerization of adiponectin.	CSNK1D CSNK1E	1.41e-05	3	76	2	25724478
Pubmed	Implication of common and disease specific variants in CLU, CR1, and PICALM.	CLU CR1	1.41e-05	3	76	2	22402018
Pubmed	A comparative study of structural and conformational properties of casein kinase-1 isoforms: insights from molecular dynamics and principal component analysis.	CSNK1D CSNK1E	1.41e-05	3	76	2	25665722
Pubmed	CRISPR-mediated gene targeting of CK1δ/ε leads to enhanced understanding of their role in endocytosis via phosphoregulation of GAPVD1.	CSNK1D CSNK1E	1.41e-05	3	76	2	32321936
Pubmed	Lack of association of CR1, PICALM and CLU gene polymorphisms with Alzheimer disease in a Polish population.	CLU CR1	1.41e-05	3	76	2	23650005
Pubmed	Casein kinase 1-epsilon or 1-delta required for Wnt-mediated intestinal stem cell maintenance.	CSNK1D CSNK1E	1.41e-05	3	76	2	28963394
Pubmed	Human Rad17 C-terminal tail is phosphorylated by concerted action of CK1δ/ε and CK2 to promote interaction with the 9-1-1 complex.	CSNK1D CSNK1E	1.41e-05	3	76	2	31353086
Pubmed	Sequence analysis of the cDNA for the human casein kinase I delta (CSNK1D) gene and its chromosomal localization.	CSNK1D CSNK1E	1.41e-05	3	76	2	8786104
Pubmed	The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.	CLU CR1	1.41e-05	3	76	2	21300948
Pubmed	Replication of CLU, CR1, and PICALM associations with alzheimer disease.	CLU CR1	1.41e-05	3	76	2	20554627
Pubmed	Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.	GBA3 GANAB GBA2	1.50e-05	22	76	3	8673525
Pubmed	Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation.	GBA3 GANAB GBA2	1.50e-05	22	76	3	9109416
Pubmed	Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum.	GBA3 GANAB GBA2	1.50e-05	22	76	3	11530211
Pubmed	Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function.	GBA3 GANAB GBA2	1.72e-05	23	76	3	1736542
Pubmed	Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.	GBA3 GANAB GBA2	1.72e-05	23	76	3	8093218
Pubmed	Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins.	GBA3 GANAB GBA2	1.72e-05	23	76	3	3099781
Pubmed	Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.	GBA3 GANAB GBA2	1.72e-05	23	76	3	3264072
Pubmed	Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.	TBC1D32 PXDN ANK2 CLU CPA2 SMPD1 NSD3	1.73e-05	371	76	7	15747579
Pubmed	Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins.	GBA3 GANAB GBA2	2.23e-05	25	76	3	2283726
Pubmed	Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system.	GBA3 GANAB GBA2	2.51e-05	26	76	3	8218172
Pubmed	CK1δ/ε protein kinase primes the PER2 circadian phosphoswitch.	CSNK1D CSNK1E	2.82e-05	4	76	2	29784789
Pubmed	Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.	CSNK1D CSNK1E	2.82e-05	4	76	2	37578019
Pubmed	Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth.	CSNK1D CSNK1E	2.82e-05	4	76	2	21422228
Pubmed	The DNA-binding activity of mouse DNA methyltransferase 1 is regulated by phosphorylation with casein kinase 1delta/epsilon.	CSNK1D CSNK1E	2.82e-05	4	76	2	20192920
Pubmed	Updated Meta-Analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 Variants in Alzheimer's Disease.	CLU CR1	2.82e-05	4	76	2	29504051
Pubmed	Therapeutic Targeting of Casein Kinase 1δ/ε in an Alzheimer's Disease Mouse Model.	CSNK1D CSNK1E	2.82e-05	4	76	2	31334659
Pubmed	p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs.	CSNK1D CSNK1E	2.82e-05	4	76	2	9349507
Pubmed	Isolation and characterization of human casein kinase I epsilon (CKI), a novel member of the CKI gene family.	CSNK1D CSNK1E	2.82e-05	4	76	2	7797465
Pubmed	Casein kinase 1 delta (CK1delta) regulates period length of the mouse suprachiasmatic circadian clock in vitro.	CSNK1D CSNK1E	2.82e-05	4	76	2	20421981
Pubmed	Deciphering complement receptor type 1 interactions with recognition proteins of the lectin complement pathway.	CR1 FCN3	2.82e-05	4	76	2	23460739
Pubmed	Involvement of casein kinase Iepsilon in cytokine-induced granulocytic differentiation.	CSNK1D CSNK1E	2.82e-05	4	76	2	15070676
Pubmed	Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton.	SEMA5A FSCN1	2.82e-05	4	76	2	21706053
Pubmed	Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease.	CLU CR1	2.82e-05	4	76	2	21347408
Pubmed	Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.	CLU CR1	2.82e-05	4	76	2	20697030
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	USP36 RPF1 GANAB SFSWAP SUPV3L1 SRPK2 EXOSC5 IDH3A WDR59	2.84e-05	723	76	9	34133714
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	CAPN13 SETD1A CSNK1D CSNK1E SRPK2 FUT7 MMP15 SMURF2 NSD3	3.06e-05	730	76	9	34857952
Pubmed	Phosphorylation of human enhancer filamentation 1 (HEF1) stimulates interaction with Polo-like kinase 1 leading to HEF1 localization to focal adhesions.	CSNK1D CSNK1E	4.69e-05	5	76	2	29191835
Pubmed	Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.	CLU CR1	4.69e-05	5	76	2	22539578
Pubmed	Control of intracellular dynamics of mammalian period proteins by casein kinase I epsilon (CKIepsilon) and CKIdelta in cultured cells.	CSNK1D CSNK1E	4.69e-05	5	76	2	11865049
Pubmed	Casein kinase 1 delta regulates the pace of the mammalian circadian clock.	CSNK1D CSNK1E	4.69e-05	5	76	2	19414593
Pubmed	Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase I epsilon.	CSNK1D CSNK1E	4.69e-05	5	76	2	10848614
Pubmed	Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.	CLU CR1	4.69e-05	5	76	2	19734903
Pubmed	APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.	CLU CR1	4.69e-05	5	76	2	20674675
Pubmed	Desynchrony between brain and peripheral clocks caused by CK1δ/ε disruption in GABA neurons does not lead to adverse metabolic outcomes.	CSNK1D CSNK1E	4.69e-05	5	76	2	29463694
Pubmed	Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases.	GBA3 GBA2	4.69e-05	5	76	2	26724485
Pubmed	Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin.	CSNK1D CSNK1E	4.69e-05	5	76	2	17027228
Pubmed	The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer.	CSNK1D CSNK1E	4.69e-05	5	76	2	33754069
Pubmed	Essential roles of CKIdelta and CKIepsilon in the mammalian circadian clock.	CSNK1D CSNK1E	4.69e-05	5	76	2	19948962
Pubmed	Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.	CSNK1D CSNK1E	7.03e-05	6	76	2	18708403
Pubmed	A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).	CSNK1D CSNK1E	7.03e-05	6	76	2	20048001
Pubmed	Phosphorylation at Ser244 by CK1 determines nuclear localization and substrate targeting of PKD2.	CSNK1D CSNK1E	7.03e-05	6	76	2	17962809
Pubmed	Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex.	CSNK1D CSNK1E	7.03e-05	6	76	2	11818547
Pubmed	Physiological role for casein kinase 1 in glutamatergic synaptic transmission.	CSNK1D CSNK1E	7.03e-05	6	76	2	16014721
Pubmed	Identification of a novel Wnt5a-CK1ɛ-Dvl2-Plk1-mediated primary cilia disassembly pathway.	CSNK1D CSNK1E	7.03e-05	6	76	2	22609948
Pubmed	High-throughput chemical screen identifies a novel potent modulator of cellular circadian rhythms and reveals CKIα as a clock regulatory kinase.	CSNK1D CSNK1E	7.03e-05	6	76	2	21179498
Pubmed	Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.	GBA3 GANAB GBA2	7.39e-05	37	76	3	2541446
Pubmed	Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport.	GBA3 GANAB GBA2	7.39e-05	37	76	3	2542563
Pubmed	Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.	CLU ADAMTS20 CR1	7.39e-05	37	76	3	24162737
Pubmed	Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis.	GBA3 GANAB GBA2	8.01e-05	38	76	3	2829950
Pubmed	Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.	GBA3 GANAB GBA2	8.01e-05	38	76	3	2187500
Pubmed	SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions.	CSNK1D CSNK1E	9.83e-05	7	76	2	34353330
Pubmed	Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia.	SEMA5A TENM2	9.83e-05	7	76	2	22229870
Pubmed	Modeling of a human circadian mutation yields insights into clock regulation by PER2.	CSNK1D CSNK1E	9.83e-05	7	76	2	17218255
Pubmed	Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.	CSNK1D CSNK1E	9.83e-05	7	76	2	12000790
Pubmed	SCFFBW7-mediated degradation of Brg1 suppresses gastric cancer metastasis.	CSNK1D CSNK1E	9.83e-05	7	76	2	30177679
Pubmed	The retinoic acid receptor beta (Rarb) region of Mmu14 is associated with prion disease incubation time in mouse.	CLU CR1	9.83e-05	7	76	2	21151910
Pubmed	Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.	CLU SMPD1 LCAT	1.01e-04	41	76	3	19878569
Pubmed	Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin.	CSNK1D CSNK1E	1.31e-04	8	76	2	17101137
Pubmed	The period of the circadian oscillator is primarily determined by the balance between casein kinase 1 and protein phosphatase 1.	CSNK1D CSNK1E	1.31e-04	8	76	2	21930935
Pubmed	Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism.	CSNK1D CSNK1E	1.31e-04	8	76	2	17244647
Pubmed	Dysbindin structural homologue CK1BP is an isoform-selective binding partner of human casein kinase-1.	CSNK1D CSNK1E	1.31e-04	8	76	2	16618118
Pubmed	Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein.	GBA3 GANAB GBA2	1.42e-04	46	76	3	2649653
Pubmed	SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation.	CSNK1D CSNK1E	1.68e-04	9	76	2	36828627
Pubmed	Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase.	CSNK1D CSNK1E	1.68e-04	9	76	2	20708156
Pubmed	Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7.	CSNK1D CSNK1E	2.10e-04	10	76	2	25500533
Pubmed	Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins.	KSR1 IL17RD	2.10e-04	10	76	2	19114553
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETD1A MECOM NSD3	8.73e-05	34	46	3	487
GeneFamily	PWWP domain containing	HDGFL1 NSD3	1.42e-03	22	46	2	1147
ToppCell	TCGA-Liver-Solid_Tissue_Normal-Liver\|TCGA-Liver / Sample_Type by Project: Shred V9	NDST3 GBA3 CYP2B6 BMPER LCAT FCN3	6.33e-07	179	76	6	0e22e840f43ca81a7543dcf33ec17a741cdf7f37
ToppCell	TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue\|TCGA-Liver / Sample_Type by Project: Shred V9	NDST3 GBA3 CYP2B6 BMPER LCAT FCN3	6.33e-07	179	76	6	17ba1eedb6ebf039d3b11d099351d0ac6363c8d1
ToppCell	TCGA-Liver-Solid_Tissue_Normal\|TCGA-Liver / Sample_Type by Project: Shred V9	NDST3 GBA3 CYP2B6 BMPER LCAT FCN3	6.33e-07	179	76	6	7046f0a426e45fe1b41a25721ee1e33f6fc7f9e3
ToppCell	TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue-2\|TCGA-Liver / Sample_Type by Project: Shred V9	NDST3 GBA3 CYP2B6 BMPER LCAT FCN3	6.33e-07	179	76	6	a20bb3ace5be10c5aef330e9268c0ba55f8fee23
ToppCell	droplet-Pancreas-Exocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLU CUZD1 CPA2 IL17RD	6.33e-06	70	76	4	26178ee967d647224d93c7a6380f2d15d8fcfb8f
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CLU CUZD1 CPA2 LCAT	6.48e-06	153	76	5	39ac25c48e73538f1c10f37bea386e0e88d3e8d0
ToppCell	LPS-antiTNF-Endothelial-Epi-like-Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF473 BSPRY KCNJ14 SMPD1 FCN3	7.34e-06	157	76	5	abfd05ed993b80822739f47a735f154092a23632
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CUZD1 ADAMTS20 CPA2 LCAT	8.30e-06	161	76	5	b9a17f41426bf715f30bf544a6795afaf37a3aa6
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CUZD1 ADAMTS20 CPA2 LCAT	8.30e-06	161	76	5	f7a89c481f789f624102857be722c95fbeb47595
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Pre-B\|bone_marrow / Manually curated celltypes from each tissue	PXDN LINGO3 LCAT WASF1 BAIAP3	8.55e-06	162	76	5	e088e66aabc307dde5d2b9aa295c34ef68155b1a
ToppCell	droplet-Pancreas-Exocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CLU CUZD1 CPA2 COL6A5	9.35e-06	165	76	5	c17e00ec9dbe30fcded65a461231dbb13665ddac
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CLU CUZD1 CPA2 LCAT	1.28e-05	176	76	5	60740f676db5d259ef3046bd5bc7b7b14924ecee
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CLU CUZD1 CPA2 LCAT	1.28e-05	176	76	5	12bccbd56742fcfe19749da802ea1cf62ec9a872
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CLU CUZD1 CPA2 LCAT	1.35e-05	178	76	5	415a02ad14df9deba988990118b00fb84ee524a8
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CLU CUZD1 CPA2 LCAT	1.46e-05	181	76	5	cf8f7798559fedf91ee21b3ebc93171cfd14f89f
ToppCell	droplet-Pancreas-PANCREAS\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CLU CUZD1 CPA2 LCAT	1.50e-05	182	76	5	ecb8c1d0b9e0766fae4dd2568456eb78a3cfce9a
ToppCell	droplet-Pancreas-PANCREAS-30m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CLU CUZD1 CPA2 LCAT	1.50e-05	182	76	5	cf1ccfc4709364763fa73e60d5f2c05ce268d5c1
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KSR1 COL6A5 EXT1 BMPER HAPLN1	1.54e-05	183	76	5	5377b4fbd8fdfe68933b4c0965aa9525f7f31591
ToppCell	systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BSPRY BMPER IDH3A FUT7 MMP15	1.62e-05	185	76	5	cc5152d3055375172bdf84f442b233c8fbd422b3
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NDST3 OTOGL BMPER WASF1 TENM2	1.71e-05	187	76	5	f18628ffc7ff7c762b8339ba8822cf0c3157f469
ToppCell	18-Distal-Mesenchymal-Cartilage\|Distal / Age, Tissue, Lineage and Cell class	CLU GABRQ MECOM BMPER HAPLN1	1.99e-05	193	76	5	52f3d1bb8d8ca91ba12439d46392f377928ff8f8
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-AT1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	PXDN ANK2 KCNMA1 SRPK3 LCAT	2.20e-05	197	76	5	f7ef62d78336812573148f8bfce401877ec4e29c
ToppCell	(5)_Fibroblast-I\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ANK2 COL6A5 BMPER FSCN1 TENM2	2.20e-05	197	76	5	eb486995ad72a0fbb6410c54e8dcf4ee780c0986
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Transitional_AT2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	NDST3 PXDN ANK2 BSPRY KCNMA1	2.30e-05	199	76	5	cd581d7330b471431ef427f8a4f5be553f70e068
ToppCell	COVID-19-COVID-19_Mild-Myeloid-pDC\|COVID-19_Mild / Disease, condition lineage and cell class	BSPRY SEMA5A IDH3A FUT7 MMP15	2.30e-05	199	76	5	9de61e5189d907cc969ac3043d68204f70acc0bf
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CLU CUZD1 CPA2	7.94e-05	133	76	4	91e4556658e49f92946d48b194df64c5fc5758fe
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLU KCNMA1 LCAT HAPLN1	1.05e-04	143	76	4	b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7
ToppCell	Club_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	KSR1 CYP2B6 CLU BMPER	1.17e-04	147	76	4	9211242a8e40d50414d310940616eccce299a7f8
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	OTOGL CUZD1 MUC5AC	1.20e-04	56	76	3	af55596513ddbe60b08648b27e41a7b65e3da58c
ToppCell	10x5'-Liver-Myeloid_Mac-Intestinal_macrophages\|Liver / Manually curated celltypes from each tissue	NDST3 KCNMA1 CR1 MMP15	1.47e-04	156	76	4	9a897fc79c4fae94c5f2e9012d65297f9225e5e3
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CAPN13 CYP2B6 CLU MECOM	1.51e-04	157	76	4	6ee2692f705bdd93ba523dffaf2f0cd921b47e28
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GREB1L NDST3 KCNMA1 TENM2	1.54e-04	158	76	4	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GREB1L NDST3 KCNMA1 TENM2	1.54e-04	158	76	4	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 NUP210 LINGO3 SSTR4	1.62e-04	160	76	4	237430af14830b38e58da8a4224036e5c6b71c5b
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CLU CUZD1 CPA2	1.70e-04	162	76	4	922ecea81063095b8dd9ac9f9792bf551edbb848
ToppCell	LAM-Myeloid-Mast\|LAM / Condition, Lineage and Cell class	P2RX1 CLU SRPK3 CRLF2	1.86e-04	166	76	4	e0ce973cc2a091b832c67b3b32dc153379daa2ef
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCDHAC1 FSCN1 TENM2 CRLF2	1.91e-04	167	76	4	8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CAPN13 BSPRY MMP15 MUC5AC	1.95e-04	168	76	4	b275e951ff7109e36da22fc17bd4516f9b9432c4
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CAPN13 BSPRY MMP15 MUC5AC	1.95e-04	168	76	4	0757a5af953901a8faed5774ffec4755fc9c0a6e
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CAPN13 BSPRY MMP15 MUC5AC	1.95e-04	168	76	4	a0dbe2ee697e29b32aa5f8326445e067ff66c154
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CAPN13 CYP2B6 COL6A5 MUC5AC	2.09e-04	171	76	4	25c1979e972c959e1ce4c57804f976f53a247ad7
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CAPN13 CYP2B6 COL6A5 MUC5AC	2.09e-04	171	76	4	fe27bf581c75ef33c2848878e51ed16b275a4c8e
ToppCell	wk_20-22-Mesenchymal-Chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CLU MECOM BMPER HAPLN1	2.09e-04	171	76	4	d2938639e9a7c349e5a6ec61724222f9d127c89f
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ZNF473 OTOGL HAPLN1	2.15e-04	68	76	3	cfd75c373e10b3761666ccd445ba74755efeb95f
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ZNF473 OTOGL HAPLN1	2.15e-04	68	76	3	c25fb921dc83eecdc337353894829ae6b5192353
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ZNF473 OTOGL HAPLN1	2.15e-04	68	76	3	712f5f4d3a1e0c0db1a340332876206b93bdac31
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PXDN SEMA5A COL6A5 BMPER	2.23e-04	174	76	4	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CUZD1 CPA2 LCAT	2.28e-04	175	76	4	7329ebb135fc4311ee9595729b62a5d152c9de8c
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D32 SETD1A NUP210 FUT7	2.28e-04	175	76	4	bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell	COVID-19-kidney-Podocyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SEMA5A CR1 IL17RD TENM2	2.28e-04	175	76	4	a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLU KCNMA1 ADAMTS20 HAPLN1	2.28e-04	175	76	4	f1394aacc8a94ca555dd19aaed5a18da99c6bf40
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLU KCNMA1 ADAMTS20 HAPLN1	2.28e-04	175	76	4	7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Paneth\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CAPN13 CLU CPA2 MUC5AC	2.38e-04	177	76	4	2af09028014f4ec3b7d2a4c286f1ae5e84a9f590
ToppCell	10x5'-GI_large-bowel-Mast\|GI_large-bowel / Manually curated celltypes from each tissue	P2RX1 CLU BSPRY CRLF2	2.43e-04	178	76	4	d10ed2543c96e1a2373f847e0b82144771e26d07
ToppCell	Children_(3_yrs)-Epithelial-basal_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CAPN13 CYP2B6 CLU MECOM	2.43e-04	178	76	4	fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell	10x5'-GI_large-bowel-Mast-Mast_cells\|GI_large-bowel / Manually curated celltypes from each tissue	P2RX1 CLU BSPRY CRLF2	2.43e-04	178	76	4	8fc5f735afa25ae43c2acb1c710ade6e9e093e3c
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-CLDN10+_cells\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	P2RX1 CLU BSPRY CPA2	2.49e-04	179	76	4	7eca1e19ae6b5b1f18c721691dc3e860705628f2
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PXDN COL6A5 BMPER HAPLN1	2.54e-04	180	76	4	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	facs-Pancreas-Exocrine-24m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 OTOGL CUZD1 CPA2	2.54e-04	180	76	4	72310baeed848f2c483ae986cd73d2fb2cca7feb
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	OTOGL SEMA5A BMPER HAPLN1	2.59e-04	181	76	4	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GREB1L NDST3 SFXN5 MECOM	2.59e-04	181	76	4	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	facs-Pancreas-Exocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RX1 CUZD1 SEMA5A CPA2	2.65e-04	182	76	4	45faefd7cbeac84d2c58650530b902af6ce921f8
ToppCell	NS-critical-d_07-13-Epithelial-Ionocyte\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PXDN ANK2 KCNMA1 SRPK3	2.70e-04	183	76	4	ba43bca2b45be1008eebd3f033cecb061fb3a966
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLU BSPRY CPA2 FUT7	2.70e-04	183	76	4	0d21befacefc6c597e7b501ed41b7fe9385a78df
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CLU PCDHAC1 SEMA5A HAPLN1	2.70e-04	183	76	4	27a57cd8ea924420e182f3d72f5b29b00dea8fa0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MFSD6 SEMA5A CR1 TENM2	2.70e-04	183	76	4	612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCell	3'_v3-lymph-node_spleen-Mast\|lymph-node_spleen / Manually curated celltypes from each tissue	P2RX1 CLU KCNMA1 CRLF2	2.76e-04	184	76	4	83675c7a083c52fb74dc8b9d35df0ef69715f707
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CAPN13 MECOM SEMA5A EXT1	2.76e-04	184	76	4	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	critical-Epithelial-Ionocyte\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PXDN ANK2 KCNMA1 SRPK3	2.76e-04	184	76	4	58d36577eff814d46d72f031f3533d71549e3d6e
ToppCell	3'_v3-lymph-node_spleen-Mast-Mast_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	P2RX1 CLU KCNMA1 CRLF2	2.76e-04	184	76	4	ed266bd2d12f86e8786473e64fbcd58319cd4c2a
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CAPN13 MECOM SEMA5A EXT1	2.76e-04	184	76	4	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ANK2 MECOM SRPK3 TENM2	2.82e-04	185	76	4	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	P2RX1 BSPRY IDH3A WASF1	2.82e-04	185	76	4	f4588468e8654363f48adbe427dff10f16f1c7fe
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	P2RX1 BSPRY IDH3A WASF1	2.82e-04	185	76	4	3cb816fc9541c04b4436e21d984216cfbbacff98
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	P2RX1 BSPRY IDH3A WASF1	2.82e-04	185	76	4	c2e70405969616c28fb6379ee318e17bbcef7b49
ToppCell	Striatum-Macroglia-ASTROCYTE-Gja1-Sparc-Astrocyte.Gja1.Sparc-Car2_(Car2)-\|Striatum / BrainAtlas - Mouse McCarroll V32	CAPN13 ERV3-1 KCNJ14	2.87e-04	75	76	3	162b69b9934da4623ee378b0e8206c4e4917351b
ToppCell	Striatum-Macroglia-ASTROCYTE-Gja1-Sparc-Astrocyte.Gja1.Sparc-Car2_(Car2)\|Striatum / BrainAtlas - Mouse McCarroll V32	CAPN13 ERV3-1 KCNJ14	2.87e-04	75	76	3	98807389b7735b90024ba5e71be60cf95416c077
ToppCell	Striatum-Macroglia-ASTROCYTE-Gja1-Sparc\|Striatum / BrainAtlas - Mouse McCarroll V32	CAPN13 ERV3-1 KCNJ14	2.87e-04	75	76	3	15505f3e7a25b3ae51f0917335e92d6279e6d06d
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CLU MECOM SRPK2 FCN3	2.88e-04	186	76	4	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	Mild-Lymphoid-pDC\|Mild / Condition, Lineage, Cell class and cell subclass	P2RX1 BSPRY IDH3A WASF1	2.88e-04	186	76	4	7fa82972c726025d6402e5eb7bf0db3b699eba4c
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSAD1 CSNK1E BMPER CDKN2AIPNL	2.88e-04	186	76	4	37860daeecd6d412bd3797f30496a56da667fbd1
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	P2RX1 BSPRY IDH3A WASF1	2.88e-04	186	76	4	b031f4e6867b6200b85f43276a34749bf5f4603f
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	P2RX1 BSPRY IDH3A WASF1	2.88e-04	186	76	4	d2fbf53aac905c9896272ec5c2db28ee1a60f4be
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSAD1 CSNK1E BMPER CDKN2AIPNL	2.88e-04	186	76	4	60830822d3de3147816693404fd03392e04c2b8e
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-CLDN10+_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	P2RX1 CLU BSPRY CPA2	2.88e-04	186	76	4	56d2f463800d189212ea0acaaf7db09b65a54eb6
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFXN5 CLU LCAT HAPLN1	2.88e-04	186	76	4	ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSAD1 CSNK1E BMPER CDKN2AIPNL	2.88e-04	186	76	4	baebeffdd426ce767190ddefc857cc78e6a58d36
ToppCell	Mild-Lymphoid-pDC-\|Mild / Condition, Lineage, Cell class and cell subclass	P2RX1 BSPRY IDH3A WASF1	2.88e-04	186	76	4	1d05e73ae2ec0cc27f79e4fa40d6b21790059f80
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	P2RX1 BSPRY IDH3A WASF1	2.88e-04	186	76	4	79aedd5aed72509a4925e9f6cb43bc0c798c86f5
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ANK2 MECOM SRPK3 TENM2	2.94e-04	187	76	4	5258674d0346e5c51a4b965efcdc1790c970845d
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	ANK2 CLU SEMA5A FCN3	2.94e-04	187	76	4	e04fb35f2f5b120659d06b5ae427ab1ec56d5c36
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUZD1 SEMA5A CPA2 MMP15	2.94e-04	187	76	4	9aa411ae9b5a923378a5daebb8bb2fc2613f2510
ToppCell	15-Trachea-Epithelial-Secretory_progenitor\|Trachea / Age, Tissue, Lineage and Cell class	CYP2B6 ERV3-1 CLU HAPLN1	2.94e-04	187	76	4	be9fce9e74b2f170a2067f1b31d802912a578329
ToppCell	Mild_COVID-19-Myeloid-pDC\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	P2RX1 BSPRY IDH3A WASF1	2.94e-04	187	76	4	99c3c4a7b9179dce7982dc6516d561c952abc80e
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MFSD6 SEMA5A CR1 TENM2	2.94e-04	187	76	4	24c2a3962da364e46e98abeab5f8234376fa26bb
ToppCell	PBMC-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	BSPRY SEMA5A IDH3A FUT7	3.00e-04	188	76	4	89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df
ToppCell	PBMC-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	BSPRY SEMA5A IDH3A FUT7	3.00e-04	188	76	4	de6a270b6e4fe09c39a52c296632d86ada98465b
ToppCell	PBMC-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BSPRY SEMA5A IDH3A FUT7	3.00e-04	188	76	4	879054b780378ae05be68e597c77c931bf0ade03
ToppCell	PBMC-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BSPRY SEMA5A IDH3A FUT7	3.06e-04	189	76	4	209cae68d78c8f72479b169e27c3ff7e143adece
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Dendritic-pDC\|lymph-node_spleen / Manually curated celltypes from each tissue	P2RX1 SEMA5A IDH3A FUT7	3.06e-04	189	76	4	6c2ace61a7d62bcf7e76b73e2da8b722d03e713b
Drug	4-hydroxycarbaryl	GBA3 CYP2B6 GBA2	1.24e-06	7	76	3	CID000021342
Drug	5-hydroxycarbaryl	GBA3 CYP2B6 GBA2	1.24e-06	7	76	3	CID000021956
Drug	NSC106556	GBA3 GBA2	1.10e-05	2	76	2	CID000267363
Drug	allylacetylene	GBA3 GBA2	1.10e-05	2	76	2	CID000522708
Drug	AC1L3ZSY	GBA3 GBA2	1.10e-05	2	76	2	CID000098102
Drug	1-hydroxy-3,7-dimethoxyxanthone	GBA3 GBA2	1.10e-05	2	76	2	CID005488808
Drug	benzene-butanol	GBA3 GBA2	1.10e-05	2	76	2	CID000076889
Drug	torvanol A	GBA3 GBA2	1.10e-05	2	76	2	CID000639650
Drug	8-Hydroxyquinoline-beta-D-glucoside	GBA3 GBA2	1.10e-05	2	76	2	CID000152983
Drug	Ccris 6118	GBA3 GBA2	1.10e-05	2	76	2	CID003085143
Drug	3alpha-dihydrocadambine	GBA3 GBA2	1.10e-05	2	76	2	CID000162138
Drug	avenacoside B	GBA3 GBA2	1.10e-05	2	76	2	CID000441878
Drug	glucocheirolin	GBA3 GBA2	1.10e-05	2	76	2	CID000656530
Drug	AC1NSZ0V	GBA3 GBA2	1.10e-05	2	76	2	CID005320067
Drug	balanitoside	GBA3 GBA2	1.10e-05	2	76	2	CID000150711
Drug	3-mat	GBA3 GBA2	1.10e-05	2	76	2	CID006453430
Drug	AC1LDLNP	GBA3 GBA2	1.10e-05	2	76	2	CID000620782
Drug	Purin-6-yl 6-deoxy-1-thio-beta-D-glucopyranoside	GBA3 GBA2	1.10e-05	2	76	2	CID000130740
Drug	3beta-isodihydrocadambine	GBA3 GBA2	1.10e-05	2	76	2	CID000188431
Drug	phenthoate oxon	GBA3 GBA2	1.10e-05	2	76	2	CID000019398
Drug	Ambap529-66-8	GBA3 GBA2	1.10e-05	2	76	2	CID003083619
Drug	DIMBOA-glucoside	GBA3 GBA2	1.10e-05	2	76	2	CID000441563
Drug	glucoside 1	GBA3 GBA2	1.10e-05	2	76	2	CID006325268
Drug	theaspirane	GBA3 GBA2	1.10e-05	2	76	2	CID000061953
Drug	dimethylbellidifolin	GBA3 GBA2	1.10e-05	2	76	2	CID005487856
Drug	3,4,6-tri-O-methyl-D-glucose	GBA3 GBA2	1.10e-05	2	76	2	CID000193713
Drug	luteone	GBA3 GBA2	1.10e-05	2	76	2	CID005281797
Drug	1,4-benzothiazine	CYP2B6 KCNMA1 SMPD1	1.94e-05	16	76	3	CID003088997
Drug	NSC103055	GBA3 GBA2	3.29e-05	3	76	2	CID000266052
Drug	torvoside H	GBA3 GBA2	3.29e-05	3	76	2	CID000639649
Drug	NSC721382	GBA3 GBA2	3.29e-05	3	76	2	CID000404838
Drug	2',4'-dinitrophenyl beta-D-galactopyranoside	GBA3 GBA2	3.29e-05	3	76	2	CID000152809
Drug	AC1Q5X08	GBA3 GBA2	3.29e-05	3	76	2	CID000125153
Drug	FU-O-G	GBA3 GBA2	3.29e-05	3	76	2	CID000125172
Drug	protogracillin	GBA3 GBA2	3.29e-05	3	76	2	CID000441892
Drug	bioside	GBA3 GBA2	3.29e-05	3	76	2	CID003084119
Drug	AC1L2O6A	GBA3 GBA2	3.29e-05	3	76	2	CID000100152
Drug	Cellobiose octaacetate	GBA3 GBA2	3.29e-05	3	76	2	CID000104455
Drug	phloroglucinaldehyde	GBA3 GBA2	3.29e-05	3	76	2	CID000068099
Drug	6-bromo-2-naphthyl-beta-d-glucoside	GBA3 GBA2	3.29e-05	3	76	2	CID000084983
Drug	3'-galactosyllactose	GBA3 GBA2	3.29e-05	3	76	2	CID000189088
Drug	virgaureasaponin	GBA3 GBA2	3.29e-05	3	76	2	CID006324777
Drug	C7UGlc	GBA3 GBA2	3.29e-05	3	76	2	CID000127569
Drug	picein	GBA3 GBA2	3.29e-05	3	76	2	CID000092123
Drug	AC1O6AB3	GBA3 GBA2	3.29e-05	3	76	2	CID006449878
Drug	5-phenylpentanol	GBA3 GBA2	3.29e-05	3	76	2	CID000061523
Drug	AC1L1C5B	GBA3 GBA2	3.29e-05	3	76	2	CID000026918
Drug	N-bromoacetyl-beta-D-galactosylamine	GBA3 GBA2	3.29e-05	3	76	2	CID000193108
Drug	bellidifolin	GBA3 GBA2	3.29e-05	3	76	2	CID005281623
Drug	norswertianolin	GBA3 GBA2	3.29e-05	3	76	2	CID005281659
Drug	swertianolin	GBA3 GBA2	3.29e-05	3	76	2	CID005281662
Drug	estrone glucoside	GBA3 GBA2	3.29e-05	3	76	2	CID000193609
Drug	dioscine	GBA3 GBA2	3.29e-05	3	76	2	CID000120694
Drug	F0447-0125; Up 200; 10uM; PC3; HT_HG-U133A	ZNF473 CLU CSNK1E FSCN1 BAIAP3 NSD3	4.20e-05	190	76	6	6429_UP
Drug	Orlistat; Up 200; 10uM; PC3; HT_HG-U133A	DNAJC16 ADAMTS20 SEMA5A DCLRE1B SSTR4 BAIAP3	4.45e-05	192	76	6	6388_UP
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A	GREB1L GPR137 CYP2B6 DNAJC16 GABRQ SMPD1	4.86e-05	195	76	6	3642_UP
Drug	Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; PC3; HT_HG-U133A	GREB1L CLU NUP210 MFSD6 SEMA5A FUT7	4.86e-05	195	76	6	4660_DN
Drug	semustine; Up 200; 100uM; MCF7; HT_HG-U133A	GPR137 ZNF473 CSNK1E CUZD1 ADAMTS20 FSCN1	4.86e-05	195	76	6	7540_UP
Drug	Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	SETD1A P2RX1 DNAJC16 CUZD1 KCNMA1 NSD3	5.00e-05	196	76	6	6483_UP
Drug	3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A	GPR137 KSR1 CYP2B6 CPA2 FSCN1 MUC5AC	5.00e-05	196	76	6	6402_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A	GPR137 ZNF473 CLU DNAJC16 CSNK1E FSCN1	5.00e-05	196	76	6	2119_DN
Drug	genistein; Up 200; 10uM; HL60; HT_HG-U133A	CYP2B6 ANK2 KCNMA1 MECOM CPA2 WDR59	5.00e-05	196	76	6	6194_UP
Drug	Luteolin [491-70-3]; Up 200; 14uM; MCF7; HT_HG-U133A	USP36 GPR137 MFSD6 CPA2 EXT1 BAIAP3	5.14e-05	197	76	6	5004_UP
Drug	Oxaprozin [21256-18-8]; Up 200; 13.6uM; PC3; HT_HG-U133A	GREB1L CYP2B6 KCNJ14 MECOM CPA2 MUC5AC	5.29e-05	198	76	6	4530_UP
Drug	Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A	GREB1L KSR1 CUZD1 FUT7 SSTR4 HAPLN1	5.29e-05	198	76	6	2313_UP
Drug	Sulfapyridine [144-83-2]; Up 200; 16uM; PC3; HT_HG-U133A	BSPRY NUP210 MFSD6 MECOM SMPD1 HAPLN1	5.29e-05	198	76	6	7151_UP
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A	GREB1L SMPD1 FSCN1 MMP15 MUC5AC BAIAP3	5.44e-05	199	76	6	4346_DN
Drug	Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A	GREB1L GPR137 P2RX1 ANK2 MFSD6 HAPLN1	5.44e-05	199	76	6	6105_UP
Drug	(R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; PC3; HT_HG-U133A	GREB1L GBA3 KCNJ14 SRPK3 SMPD1 HAPLN1	5.44e-05	199	76	6	4259_UP
Drug	Nitrofural [59-87-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A	DNAJC16 KCNMA1 GABRQ SEMA5A BAIAP3 NSD3	5.44e-05	199	76	6	3320_UP
Drug	Fenbendazole [43210-67-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	CSNK1E NUP210 CUZD1 MECOM FSCN1 BAIAP3	5.59e-05	200	76	6	4542_DN
Drug	kenposide A	GBA3 GBA2	6.57e-05	4	76	2	CID006439502
Drug	AC1LEHHP	GBA3 GBA2	6.57e-05	4	76	2	CID000712271
Drug	lucumin	GBA3 GBA2	6.57e-05	4	76	2	CID000184959
Drug	gypenoside XVII	GBA3 GBA2	6.57e-05	4	76	2	CID010373670
Drug	2-deoxy-2-fluoro-beta-D-glucopyranosyl fluoride	GBA3 GBA2	6.57e-05	4	76	2	CID000163491
Drug	1,9-nonanediol	GBA3 GBA2	6.57e-05	4	76	2	CID000019835
Drug	5-hydroxy-2-nitrobenzaldehyde	GBA3 GBA2	6.57e-05	4	76	2	CID000039211
Drug	passibiflorin	GBA3 GBA2	6.57e-05	4	76	2	CID000126775
Drug	N-hexylglucosylsphingosine	GBA3 GBA2	6.57e-05	4	76	2	CID006443782
Drug	Flusoxololum	GBA3 GBA2	6.57e-05	4	76	2	CID000071765
Drug	tetraphyllin B	GBA3 GBA2	6.57e-05	4	76	2	CID000115164
Drug	4-nitroso-m-cresol	GBA3 GBA2	6.57e-05	4	76	2	CID000011981
Drug	Cardiospermin	GBA3 GBA2	6.57e-05	4	76	2	CID000179647
Drug	4'-O-(beta-D-glucopyranosyl)-D-pantothenic acid	GBA3 GBA2	6.57e-05	4	76	2	CID003082306
Drug	AC1L3SUX	GBA3 GBA2	6.57e-05	4	76	2	CID000094767
Drug	N-phenylglycolhydroxamate	GBA3 GBA2	6.57e-05	4	76	2	CID000115251
Drug	1,3,7-trimethoxyxanthone	GBA3 GBA2	6.57e-05	4	76	2	CID000145706
Drug	neolinustatin	GBA3 GBA2	6.57e-05	4	76	2	CID000119533
Drug	linustatin	GBA3 GBA2	6.57e-05	4	76	2	CID000119301
Drug	1,7-heptanediol	GBA3 GBA2	6.57e-05	4	76	2	CID000012381
Drug	NSC370274	GBA3 GBA2	6.57e-05	4	76	2	CID000122812
Drug	phellamurin	GBA3 GBA2	6.57e-05	4	76	2	CID000193876
Drug	gentisin	GBA3 GBA2	6.57e-05	4	76	2	CID005281636
Drug	isogentisin	GBA3 GBA2	6.57e-05	4	76	2	CID005281640
Drug	beta-D-glucopyranosyl isothiocyanate	GBA3 GBA2	6.57e-05	4	76	2	CID000191151
Drug	cathenamine	GBA3 GBA2	6.57e-05	4	76	2	CID000443361
Drug	4-phenylimidazole	GBA3 CYP2B6 GBA2	6.88e-05	24	76	3	CID000069590
Drug	ethyl mandelate	GBA3 GBA2	1.09e-04	5	76	2	CID000013050
Drug	gluconohydroximo-1,5-lactone	GBA3 GBA2	1.09e-04	5	76	2	CID009576855
Disease	Alzheimer disease, fasting blood insulin measurement	CLU CR1	3.81e-05	4	75	2	EFO_0004466, MONDO_0004975
Disease	syndromic X-linked intellectual disability Najm type (implicated_via_orthology)	CSNK1D CSNK1E	1.33e-04	7	75	2	DOID:0060807 (implicated_via_orthology)
Disease	common bile duct neoplasm (is_marker_for)	FSCN1 MUC5AC	1.77e-04	8	75	2	DOID:4608 (is_marker_for)
Disease	Mental deterioration	CLU CR1	2.27e-04	9	75	2	C0234985
Disease	Mild cognitive disorder	CLU CR1	2.27e-04	9	75	2	C1270972
Disease	phosphocreatine measurement	ADAMTS20 TENM2	4.88e-04	13	75	2	EFO_0010521
Disease	Impaired cognition	CLU CR1	5.69e-04	14	75	2	C0338656
Disease	family history of Alzheimer’s disease	CLU CR1 IL17RD	7.96e-04	71	75	3	EFO_0009268
Disease	severe acute respiratory syndrome, COVID-19	KSR1 PXDN NUP210 KCNMA1 TENM2 CRLF2	9.75e-04	447	75	6	EFO_0000694, MONDO_0100096

Protein segments in the cluster

Peptide	Gene	Start	Entry
RSTQQFRVFESFYEH	ERV3-1	246	Q14264
SIVFGKRFHYQDQEF	CYP2B6	181	P20813
FNYEQSHIFGLRDFI	TBC1D32	846	Q96NH3
NRDVSADFYSRFHFT	BAIAP3	936	O94812
ARYENTLAAQFFGHT	SMPD1	446	P17405
RRERSGNFNFGAYHT	CPA2	111	P48052
QSFSHQYAGIFRFRF	CAPN13	116	Q6MZZ7
EFLHRVADTFQDYFG	AP3M1	81	Q9Y2T2
FFQAGYSSRRFDQQV	DCLRE1B	511	Q9H816
FTFVNGHSRDYDFTS	ATG4C	416	Q96DT6
FRTHYRFTAYGQLFQ	ADAMTS20	76	P59510
FEEVQFFNRNNYHRG	NDST3	631	O95803
EQGFRQAYRAQSHSF	HDHD3	46	Q9BSH5
AYFTEIRNFIGNSNH	MECOM	1021	Q03112
KRSYADESFHFFQIG	ANK2	3121	Q01484
AYDQEGRRFDNFSSL	NUP210	791	Q8TEM1
FNGNRTFAHYATFRL	FCN3	186	O75636
NESNYHPFFFRTRAC	IL17RD	171	Q8NFM7
FKRHFTQVEFYQGSV	KCNMA1	456	Q12791
NRYQVFFFGTHETAF	HDGFL1	36	Q5TGJ6
NGQVFASRSYFFDRA	GPR137	311	Q96N19
RHSYGVRFNGFQADD	GABRQ	461	Q9UN88
GHTFFFQEDRYWRFN	MMP15	476	P51511
QRDSRFNFPAAYFIH	KSR1	481	Q8IVT5
QLFRNLFHRQGFSYD	CSNK1D	271	P48730
QYRFYLSFENSQHRD	FUT7	221	Q11130
FDESFFHFPFNSERR	DNAJC16	121	Q9Y2G8
RGQHKNNFSVEYSFR	LINGO3	556	P0C6S8
DFDTFQNLRDEGYTF	MUC5AC	1601	P98088
AAAQAASQHVFRFYR	EXOSC5	211	Q9NQT4
YSRTNLTFHYRFNGD	CRLF2	51	Q9HC73
ATQFRFRYNHFKNDD	MFSD6	386	Q6ZSS7
CGERGFRYFTEFSNH	GREB1L	186	Q9C091
FQRGSQYEVDYRHFH	KCNJ14	336	Q9UNX9
TSFDFEQLRGFHFQV	PCDHAC1	511	Q9H158
EFAFEYARNNHRSNV	IDH3A	181	P50213
VFSRYDQEFRFSHNG	BSPRY	326	Q5W0U4
HYNTFDGRTFNFQGT	BMPER	371	Q8N8U9
FYFGGLQFRASRSHS	EXT1	21	Q16394
FQDQRYSVQTADHRF	FSCN1	181	Q16658
DFISTNRENFHYGSV	CR1	176	P17927
DFISTNRENFHYGSV	CR1	626	P17927
DFISTNRENFHYGSV	CR1	1076	P17927
HYRRYTRFFGQDGDA	GBA2	426	Q9HCG7
NQGYSSRFGLFHVDF	GBA3	426	Q9H227
HEFSSFEFGKRFDYR	COL6A5	1346	A8TX70
NYTGRDFQRFFADLH	LCAT	296	P04180
DFGRANHVQADFYRK	C5orf49	116	A4QMS7
HYGRFQFNAFKFLRS	CUZD1	476	Q86UP6
FQQRLDHFNFERFGN	DPP7	36	Q9UHL4
FSRDDVALNNFSRYF	FTMT	101	Q8N4E7
DIHFGFRFNLSSYTE	OTOGL	1666	Q3ZCN5
SRYDVFCFTSNFNGR	HAPLN1	246	P10915
FRFARHFVENGTNYR	P2RX1	291	P51575
EAGFHQYEVSNFARN	RSAD1	266	Q9HA92
RNSQFDFLRFDHYLN	SFSWAP	236	Q12872
LDDGHTFNYQTRQEF	GANAB	846	Q14697
YGFLSDNFRRFFQRV	SSTR4	311	P31391
RSNAEFVIHSGFFFD	SETD3	316	Q86TU7
NARFDYTYHDNSFRI	TENM2	2086	Q9NT68
DARLFHQAFISFRNY	SUPV3L1	116	Q8IYB8
SENSYQDAFSRRHFS	SETD1A	301	O15047
GNFTYFFFRENAVEH	SEMA5A	226	Q13591
AFALSGRYSREFFNR	SRPK3	491	Q9UPE1
GVRQAADFAEQFRSY	CDKN2AIPNL	16	Q96HQ2
FQDRFFTREPQDTYH	CLU	191	P10909
GRVYFVDHNNRTTQF	SMURF2	311	Q9HAU4
RQVATFHNQRDYIFF	RPF1	276	Q9H9Y2
RHFALSGKYSREFFN	SRPK2	611	P78362
TRGQFNAFSYHFRGR	PXDN	1321	Q92626
NAFSYHFRGRRSLEF	PXDN	1326	Q92626
IAREEASNFRSNFGY	PSMA3	91	P25788
NTRGAREYHVQFFSN	NSD3	301	Q9BZ95
DSFAHYFAASSNQRV	WDR59	71	Q6PJI9
IFGELFNEAHSFSFR	WASF1	51	Q92558
RFQQTSFYGRFRHFL	SFXN5	31	Q8TD22
FRFGNQEDAHEFLRY	USP36	201	Q9P275
YRGEFFSYSDHSQQD	ZNF473	186	Q8WTR7
QLFRNLFHRQGFSYD	CSNK1E	271	P49674
FGHERYENGAFQERA	DTYMK	146	P23919